Posts

The Importance of CPD Hours for Oncology Professionals in Advancing Cancer Care

  In the rapidly evolving field of oncology, continuous learning is not just beneficial—it is essential. With new therapies, diagnostic technologies, and treatment protocols emerging every year, healthcare professionals must remain up to date to deliver the highest standard of patient care. This is where Continuing Professional Development (CPD) hours play a critical role in shaping competent, confident, and future-ready oncology practitioners. Keeping Pace with Rapid Scientific Advancements Cancer research is advancing at an unprecedented rate. Breakthroughs in immunotherapy, targeted therapy, precision medicine, and AI-driven diagnostics are transforming how cancer is detected and treated. CPD activities allow oncology professionals to stay aligned with: The latest clinical guidelines and treatment pathways Newly approved drugs and therapeutic approaches Advances in radiation, surgical, and systemic treatments Evolving standards in multidisciplinary cancer care By earning CPD ho...

Dr. Muna Abuayyash Joins as Delegate at the 12th International Cancer, Oncology & Therapy Conference 2026

Dr. Muna Abuayyash Joins as Delegate at the 12th International Cancer, Oncology & Therapy Conference 2026 The 12th International Cancer, Oncology & Therapy Conference 2026 is honored to welcome Dr. Muna Abuayyash, United Kingdom , as a distinguished Delegate to this globally anticipated gathering of oncology professionals. Scheduled to take place April 09–11, 2026, at Novotel Dubai Al Barsha, UAE , the conference will bring together leading oncologists, researchers, clinicians, and healthcare innovators committed to advancing cancer research, diagnostics, and therapeutic strategies. Dr. Abuayyash’s participation reflects the strong international collaboration that continues to drive progress in oncology care and patient outcomes. As a delegate, Dr. Abuayyash will engage in high-level scientific discussions, knowledge exchange sessions, and networking opportunities designed to foster multidisciplinary cooperation. The event will explore emerging trends in precision medicine, ...

Welcoming International Participation: Dr. Craina Marius Lucian Joins as Delegate

  The 12th International Cancer, Oncology & Therapy Conference & Exhibition is delighted to welcome Dr. Craina Marius Lucian from Romania as a Delegate/Listener , representing the County Emergency Hospital “Pius Brinzeu” Timisoara and the Victor Babes University of Medicine and Pharmacy – Timisoara . Strengthening Global Collaboration in Oncology International participation is at the heart of advancing cancer research and care. The presence of dedicated clinicians and academics like Dr. Craina reflects a shared global commitment to improving oncology outcomes through knowledge exchange, interdisciplinary dialogue, and exposure to the latest scientific advancements. As a delegate, Dr. Craina will engage with leading experts, researchers, and healthcare professionals from around the world, gaining insights into: Emerging innovations in cancer diagnosis and treatment Advances in precision medicine and targeted therapies Developments in pathology, laboratory medicine, and tr...

Featured Speaker Announcement: Dr. Maria Putova

  Featured Speaker Announcement: Dr. Maria Putova 12th International Cancer, Oncology & Therapy Conference & Exhibition The 12th International Cancer, Oncology & Therapy Conference & Exhibition is proud to welcome Dr. Maria Putova , a distinguished Biologist-Researcher in Clinical Laboratory Diagnostics at the Moscow Clinical Scientific Center , Moscow, Russia. With a strong background in cytopathology and laboratory medicine, Dr. Putova brings valuable scientific insight into the evolving landscape of cancer diagnostics. Presentation Highlight “Role of Immunocytochemical Tests in Cytological Diagnostics.” In modern oncology, accurate and early diagnosis plays a critical role in determining effective treatment strategies. Immunocytochemical testing has emerged as a powerful complement to traditional cytological methods, enabling clinicians and researchers to identify specific cellular markers that help differentiate tumor types and better understand disease progr...